The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis

被引:22
|
作者
Toya, Yosuke [1 ]
Chiba, Toshimi [1 ]
Mizutani, Tomomi [1 ]
Sato, Kunihiko [1 ]
Kasugai, Satoshi [1 ]
Matsuda, Nozomi [1 ]
Orikasa, Shunsuke [1 ]
Shibata, Sho [1 ]
Abiko, Yukito [1 ]
Akasaka, Risaburo [1 ]
Yokoyama, Naoki [1 ]
Oana, Shuhei [1 ]
Hirota, Shigeru [1 ]
Endo, Masaki [1 ]
Suzuki, Kazuyuki [1 ]
机构
[1] Iwate Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Morioka, Iwate 0208505, Japan
关键词
Ulcerative colitis; Granulocyte and monocyte adsorptive apheresis; GMA; Cytokine levels; Interleukin-10; INFLAMMATORY-BOWEL-DISEASE; REFRACTORY CROHNS-DISEASE; POLYMORPHONUCLEAR NEUTROPHILS; SELECTIVE LEUKOCYTAPHERESIS; INTESTINAL INFLAMMATION; INDUCIBLE PROTEIN-10; T-CELLS; ADACOLUMN; EFFICACY; THERAPY;
D O I
10.1016/j.cyto.2013.01.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Granulocyte and monocyte adsorptive apheresis (GMA) with an Adacolumn has been reported to be effective as induction therapy in ulcerative colitis (UC). However, the effects of GMA on serial changes in cytokine levels have not been well characterized. We therefore, investigated cytokine levels in UC patients before and after treatment with GMA. A total of 16 patients with active UC, 10 men, and six women, mean age, 42.6 years were included. Fourteen patients had total colitis and two patients had left-sided colitis. The study included nine patients with a chronic intermittent course, six with a chronic continuous course and one with a single episode. The duration of each GMA session was 60 min at a flow rate of 30 mL/min as per study protocol. Serum levels of 17 cytokines were determined simultaneously using a Bio-Plex suspension array system before and after treatment with GMA. Serum interleukin (IL)-10 and macrophage inflammatory protein-1 beta levels were increased significantly in UC patients after GMA treatment compared to pre-treatment levels (P < 0.05). In particular, GMA treatment caused a significant increase in serum IL-10 levels compared to pre-treatment in patients with total colitis or with a chronic intermittent UC course. In conclusion, this investigation showed that GMA was associated with a marked increase in serum level of the anti-inflammatory cytokine, IL-10. The rise in circulating IL-10 is interesting, and potentially a significant factor in the efficacy of GMA in patients with inflammatory bowel diseases. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:146 / 150
页数:5
相关论文
共 50 条
  • [31] Potential role of granulocyte/monocyte adsorptive apheresis for ulcerative colitis with concomitant CMV infection
    Nakase, H.
    Matsuura, M.
    Chiba, T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (04) : 497 - 498
  • [32] Clinical Effectiveness of Selective Granulocyte, Monocyte Adsorptive Apheresis with the Adacolumn® Device in Ulcerative Colitis
    Brigitte Habermalz
    Stefan Sauerland
    Digestive Diseases and Sciences, 2010, 55 : 1421 - 1428
  • [33] Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
    Tanida, Satoshi
    Ozeki, Keiji
    Kanno, Takuya
    Katano, Takahito
    Sugimura, Naomi
    Nishie, Hirotada
    Iwasaki, Hiroyasu
    Tanaka, Mamoru
    Shimura, Takaya
    Kubota, Eiji
    Kataoka, Hiromi
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2021, 13 (10-11): : 510 - 514
  • [34] Combined effects of granulocyte and monocyte adsorption apheresis and corticosteroids on ulcerative colitis
    Tsuzuki, Yoshikazu
    Shiomi, Rie
    Matsumoto, Hisashi
    Miyaguchi, Kazuya
    Kusano, Takeru
    Ohgo, Hideki
    Nakamoto, Hidetomo
    Imaeda, Hiroyuki
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2023, 72 (01) : 68 - 73
  • [35] Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study
    Ueno, Nobuhiro
    Sugiyama, Yuya
    Kobayashi, Yu
    Murakami, Yuki
    Iwama, Takuya
    Sasaki, Takahiro
    Kunogi, Takehito
    Takahashi, Keitaro
    Tanaka, Kazuyuki
    Ando, Katsuyoshi
    Kashima, Shin
    Inaba, Yuhei
    Moriichi, Kentaro
    Tanabe, Hiroki
    Taruishi, Masaki
    Saitoh, Yusuke
    Okumura, Toshikatsu
    Fujiya, Mikihiro
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [36] The combination of granulocyte-monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?
    Rodriguez-Lago, Iago
    Benitez, Jose M.
    Sempere, Laura
    Saez-Gonzalez, Esteban
    Barreiro-de Acosta, Manuel
    de Zarate, Jone O.
    Cabriada, Jose L.
    JOURNAL OF CLINICAL APHERESIS, 2019, 34 (06) : 680 - 685
  • [37] Efficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitis
    Tarja Ruuska
    Peter Küster
    Lena Grahnquist
    Fredrik Lindgren
    Anne Vibeke Wewer
    World Journal of Gastroenterology, 2016, 22 (17) : 4389 - 4396
  • [38] Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA
    Yoko Yokoyama
    Mikio Kawai
    Ken Fukunaga
    Koji Kamikozuru
    Kazuko Nagase
    Koji Nogami
    Tomoaki Kono
    Yoshio Ohda
    Masaki Iimuro
    Nobuyuki Hida
    Shiro Nakamura
    Hiroto Miwa
    Takayuki Matsumoto
    BMC Gastroenterology, 13
  • [39] Immunomodulatory Effects of Granulocyte and Monocyte Adsorption Apheresis as a Treatment for Patients with Ulcerative Colitis
    Nobuhito Kashiwagi
    Kazuhito Sugimura
    Hirobumi Koiwai
    Hironori Yamamoto
    Toshikazu Yoshikawa
    Abby R. Saniabadi
    Masakazu Adachi
    Takashi Shimoyama
    Digestive Diseases and Sciences, 2002, 47 : 1334 - 1341
  • [40] Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis
    Kashiwagi, N
    Sugimura, K
    Koiwai, H
    Yamamoto, H
    Yoshikawa, T
    Saniabadi, AR
    Adachi, M
    Shimoyama, T
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (06) : 1334 - 1341